HIAHX Holdings — Hartford Healthcare Hls Fund
All 86 reported holdings of Hartford Healthcare Hls Fund (HIAHX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 12.09% | $12.63M |
| Merck & Co Inc | 6.71% | $7.01M |
| Johnson & Johnson | 6.05% | $6.32M |
| UnitedHealth Group Inc | 4.11% | $4.30M |
| Intuitive Surgical Inc | 3.53% | $3.69M |
| AbbVie Inc | 3.19% | $3.33M |
| Abbott Laboratories | 2.88% | $3.01M |
| Danaher Corp | 2.84% | $2.96M |
| Edwards Lifesciences Corp | 2.73% | $2.85M |
| Vertex Pharmaceuticals Inc | 2.50% | $2.61M |
| Boston Scientific Corp | 2.21% | $2.31M |
| CVS Health Corp | 2.10% | $2.19M |
| Cencora Inc | 1.97% | $2.06M |
| Regeneron Pharmaceuticals Inc | 1.87% | $1.95M |
| HCA Healthcare Inc | 1.86% | $1.94M |
| Thermo Fisher Scientific Inc | 1.71% | $1.78M |
| Elevance Health Inc | 1.60% | $1.67M |
| Medtronic PLC | 1.45% | $1.51M |
| Cardinal Health Inc | 1.39% | $1.45M |
| Gsk PLC | 1.36% | $1.42M |
| Agilent Technologies Inc | 1.25% | $1.31M |
| United Therapeutics Corp | 1.23% | $1.29M |
| Stryker Corp | 1.13% | $1.18M |
| Argenx SE | 1.07% | $1.12M |
| Ucb SA | 1.05% | $1.10M |
| Dexcom Inc | 1.01% | $1.06M |
| Biogen Inc | 0.96% | $1.00M |
| Apellis Pharmaceuticals Inc | 0.91% | $950.96K |
| Steris PLC | 0.86% | $894.03K |
| Ionis Pharmaceuticals Inc | 0.81% | $843.79K |
| Incyte Corp | 0.79% | $822.89K |
| Alnylam Pharmaceuticals Inc | 0.78% | $815.26K |
| Madrigal Pharmaceuticals Inc | 0.77% | $804.05K |
| Ascendis Pharma A/S | 0.76% | $791.41K |
| Bristol-Myers Squibb Co | 0.74% | $777.05K |
| Elanco Animal Health Inc | 0.71% | $741.93K |
| Galderma Group AG | 0.70% | $726.19K |
| Cytokinetics Inc | 0.68% | $712.82K |
| Encompass Health Corp | 0.64% | $671.60K |
| Protagonist Therapeutics Inc | 0.64% | $665.81K |
| State Street Global Advisors | 0.62% | $648.59K |
| Revolution Medicines Inc | 0.62% | $643.02K |
| Bio-Techne Corp | 0.60% | $627.54K |
| Disc Medicine Inc | 0.58% | $609.80K |
| Alignment Healthcare Inc | 0.58% | $608.31K |
| Pharvaris NV | 0.57% | $598.79K |
| HeartFlow Inc | 0.57% | $591.51K |
| Option Care Health Inc | 0.53% | $548.98K |
| Scholar Rock Holding Corp | 0.51% | $534.07K |
| Icon PLC | 0.51% | $532.61K |
| Apogee Therapeutics Inc | 0.50% | $525.47K |
| Avantor Inc | 0.50% | $517.53K |
| Dianthus Therapeutics Inc | 0.49% | $514.09K |
| Kymera Therapeutics Inc | 0.48% | $502.99K |
| PTC Therapeutics Inc | 0.48% | $502.05K |
| Mirum Pharmaceuticals Inc | 0.48% | $498.76K |
| Structure Therapeutics Inc | 0.47% | $488.41K |
| Arcus Biosciences Inc | 0.47% | $485.85K |
| Natera Inc | 0.46% | $478.78K |
| Viridian Therapeutics Inc | 0.46% | $477.07K |
| Qiagen NV | 0.46% | $475.27K |
| Oculis Holding AG | 0.44% | $463.78K |
| Xenon Pharmaceuticals Inc | 0.42% | $443.34K |
| Acadia Healthcare Co Inc | 0.42% | $434.42K |
| Adaptive Biotechnologies Corp | 0.41% | $428.35K |
| AstraZeneca PLC | 0.41% | $427.38K |
| Nuvalent Inc | 0.40% | $420.35K |
| Celldex Therapeutics Inc | 0.38% | $398.69K |
| Vaxcyte Inc | 0.38% | $397.47K |
| Mineralys Therapeutics Inc | 0.37% | $390.66K |
| Soleno Therapeutics Inc | 0.37% | $390.31K |
| GenFleet Therapeutics Shanghai Inc | 0.37% | $389.56K |
| Inspire Medical Systems Inc | 0.37% | $383.34K |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 0.36% | $380.73K |
| Immunocore Holdings PLC | 0.35% | $365.57K |
| Immunome Inc | 0.35% | $362.80K |
| Stoke Therapeutics Inc | 0.34% | $352.95K |
| Trevi Therapeutics Inc | 0.33% | $345.08K |
| Crinetics Pharmaceuticals Inc | 0.28% | $295.72K |
| Aktis Oncology Inc | 0.25% | $260.00K |
| Newamsterdam Pharma Co NV | 0.24% | $245.93K |
| CG oncology Inc | 0.12% | $126.90K |
| Fixed Income Clearing Corp. | 0.11% | $112.44K |
| Corvus Pharmaceuticals Inc | 0.06% | $58.52K |
| Eikon Therapeutics Inc | 0.02% | $22.22K |
| Contra Abiomed, Inc. | 0.00% | $903 |
HIAHX overview: performance, fees, allocation and SEC filings